Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Covalon Technologies ( (TSE:COV) ) has issued an update.
Covalon Technologies reported that shareholders approved all matters at its fiscal 2025 annual general and special meeting held on March 25, 2026, with 36.777% of shares represented. Resolutions passed included the election of the board, reappointment of PricewaterhouseCoopers LLP as auditor, and ratification of option grants to the chief operating officer.
Investors also backed amendments to Covalon’s articles to authorize classes of preferred shares, adoption of updated corporate by-laws including a new advance notice by-law, and an amended long-term omnibus incentive plan. These approvals strengthen the company’s corporate governance framework and give the board greater capital-structure flexibility as Covalon advances its medical technologies business.
The most recent analyst rating on (TSE:COV) stock is a Buy with a C$2.00 price target. To see the full list of analyst forecasts on Covalon Technologies stock, see the TSE:COV Stock Forecast page.
Spark’s Take on COV Stock
According to Spark, TipRanks’ AI Analyst, COV is a Neutral.
The score is primarily supported by improved profitability versus 2022–2023 and strong TTM cash generation alongside low leverage. It is held back by the recent TTM margin and revenue step-down and a high P/E (~51), while technicals are mixed (shorter-term strength but still below the 200-day trend with slightly negative MACD).
To see Spark’s full report on COV stock, click here.
More about Covalon Technologies
Covalon Technologies Ltd. is a Canadian MedTech company specializing in advanced wound care, vascular access, and surgical consumables, with products aimed at improving healing, reducing healthcare-associated infections, and protecting skin integrity. The company is listed on the TSX Venture Exchange under COV and trades on the OTCQX Market under the ticker CVALF.
Average Trading Volume: 16,102
Technical Sentiment Signal: Sell
Current Market Cap: C$47.5M
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.